Early-stage Alzheimer's disease (AD) remains difficult to assess using conventional linguistic or cognitive assessments, which often overlook subtle and individualized disruptions in speech. In this work, we propose a novel biomarker discovery framework that ... ...

请注册登录后继续浏览